• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (6)
    • Cell Death
    • Leman, Robert
    • Mood Disorders
    • Receptor Activity-Modifying Proteins
    • Stromal cell-derived factor 1a mediates resistance to mTOR-directed therapy in pancreatic cancer.
    • See All 6 Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Stromal cell-derived factor 1a mediates resistance to mTOR-directed therapy in pancreatic cancer.

Stromal cell-derived factor 1a mediates resistance to mTOR-directed therapy in pancreatic cancer. Neoplasia. 2012 Aug; 14(8):690-701.

View in: PubMed

subject areas
  • Animals
  • Cell Line, Tumor
  • Chemokine CXCL12
  • Cyclin D1
  • Drug Resistance, Neoplasm
  • ErbB Receptors
  • Erlotinib Hydrochloride
  • Female
  • Humans
  • Mice
  • Mice, Nude
  • Neoplasm Transplantation
  • Pancreatic Neoplasms
  • Phosphatidylinositol 3-Kinases
  • Phosphorylation
  • Protein Kinase Inhibitors
  • Proto-Oncogene Proteins c-myc
  • Pyridines
  • Quinazolines
  • Receptors, CXCR
  • Receptors, CXCR4
  • RNA Interference
  • RNA, Small Interfering
  • Signal Transduction
  • Sirolimus
  • TOR Serine-Threonine Kinases
  • Transplantation, Heterologous
  • Tumor Microenvironment
  • Vascular Endothelial Growth Factor A

authors with profiles
  • Elizabeth Garrett Garrett-Mayer